Buy Avanafil / Dapoxetine Hydrochloride online in the UK – fast delivery from a trusted pharmacy

Avanafil, a selective phosphodiesterase type 5 (PDE-5) inhibitor, was approved by the U.S. FDA in 2012 for erectile dysfunction and is noted for rapid onset, commonly within 15–30 minutes after administration. Dapoxetine hydrochloride is a short-acting serotonin reuptake inhibitor developed specifically for on-demand management of premature ejaculation and has been approved in several jurisdictions; peak plasma levels typically occur within 1–2 hours, supporting timing before anticipated sexual activity.

Overview of Avanafil / Dapoxetine Hydrochloride and its drug class

Mechanistically, avanafil inhibits PDE-5, increasing cyclic guanosine monophosphate (cGMP) in response to nitric oxide. This facilitates smooth muscle relaxation and penile engorgement when sexual stimulation is present, without inducing spontaneous erections in the absence of stimulation.

Dapoxetine is an SSRI with a relatively rapid onset and short elimination half-life, designed to delay ejaculation by enhancing serotonergic signaling in central pathways that regulate latency and emission. Its short duration supports on-demand use with a relatively small impact on baseline mood for many patients.

How it compares to related substances in the same class

Compared with other PDE-5 inhibitors, avanafil tends to have a faster onset and shorter overall duration, with less variability in absorption and a lower likelihood of certain adverse effects such as visual disturbances in some users. It is generally less affected by fatty meals than sildenafil or vardenafil, and can be taken closer to sexual activity.

From a safety perspective, dosing regimens reflect class differences. Sildenafil and vardenafil may require longer lead times and have a higher incidence of certain adverse effects, whereas tadalafil offers a longer window and daily-dosing options. Across the class, concomitant nitrates remain contraindicated.

Therapeutic uses

Avanafil is indicated for adult men with erectile dysfunction to facilitate erection in response to sexual stimulation. It is administered on demand, typically prior to activity, with dosage adjusted for efficacy and tolerability. Dapoxetine is indicated for premature ejaculation, used on demand 1–3 hours before expected intercourse, with dose adjustments based on tolerability.

Contraindications and cautions apply to each agent. PDE-5 inhibitors are contraindicated with nitrates or nitrate therapies due to risk of profound hypotension; use with caution in severe cardiovascular disease and in patients taking alpha-blockers. Dapoxetine carries warnings for hyponatremia, potential interactions with other serotonergic medicines, and monitoring for mood changes or suicidality; hepatic impairment warrants careful consideration.

Key differences from similar medications

Key differences among PDE-5 inhibitors include onset, duration, and pharmacokinetic considerations. The following summary table contrasts common agents used for erectile dysfunction management.

Clinicians choose based on timing needs, meal effects, and patient comorbidity. Individual response and tolerability guide selection among PDE-5 inhibitors.

Safety profile summary

Common adverse effects for avanafil and related PDE-5 inhibitors include headache, flushing, nasal congestion, and dyspepsia; rare events include priapism and sudden vision or hearing changes. Dapoxetine commonly causes nausea, dizziness, and dry mouth, with possible blood pressure effects and interactions with other serotonergic agents. All agents require avoidance of nitrates and careful use in hepatic or renal impairment, with attention to drug interactions and patient history.

Ongoing counseling and pharmacovigilance are essential. Patients should report any unexpected cardiovascular symptoms, auditory or visual disturbances, or mood changes. Therapy should be individualized, balancing onset timing, duration, and safety considerations for optimal outcomes.